News tagged with hematologist
Hematology
Hematology, also spelled haematology (from the Greek αἷμα haima "blood" and -λoγία), is the branch of biology physiology, internal medicine, pathology, clinical laboratory work, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases. The laboratory work that goes into the study of blood is frequently performed by a medical technologist. Hematologists physicians also very frequently do further study in oncology - the medical treatment of cancer.
Blood diseases affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, the mechanism of coagulation, etc.
Physicians specialized in hematology are known as hematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the hematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various hematological test results. In some institutions, hematologists also manage the hematology laboratory. Physicians who work in hematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologists. Hematologists and hematopathologists generally work in conjunction to formulate a diagnosis and deliver the most appropriate therapy if needed. Hematology is a distinct subspecialty of internal medicine, separate from but overlapping with the subspecialty of medical oncology. Hematologists may specialize further or have special interests, for example in:
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
New multiple myeloma treatment guidelines personalize therapy for patients
Researchers at Mayo Clinic Cancer Center have developed new guidelines to treat recently diagnosed multiple myeloma patients who are not participating in clinical trials. The guidelines give physicians practical, easy to ...
Cancer
Apr 01, 2013 |
not rated yet |
0
Physician spouses very satisfied in relationships, study finds
It appears that the majority of spouses/partners of physicians in the United States are happy with their relationships, according to Mayo Clinic research. Of the about 900 spouses/partners of physicians who responded to a ...
Other
Mar 28, 2013 |
not rated yet |
0
Landmark study in blood stem cell transplant
(Medical Xpress)—Before all the excitement about embryonic stem cells, doctors were using hematopoetic – that is, blood-forming—stem cells. Hematopoetic stem cells can replenish all the types of cells in the blood, ...
Medical research
Jan 04, 2013 |
5 / 5 (2) |
0
|
Into adulthood, sickle cell patients rely on ER
Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers at Washington University School of Medicine in St. Louis.
Diseases, Conditions, Syndromes
Dec 10, 2012 |
not rated yet |
0
Mayo Clinic physicians ID reasons for high cost of cancer drugs, prescribe solutions
A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians ...
Cancer
Oct 01, 2012 |
5 / 5 (1) |
0
Study IDs immune system glitch tied to fourfold higher likelihood of death
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; ...
Immunology
Jun 04, 2012 |
5 / 5 (1) |
0
|
Exhaustion renders immune cells less effective in cancer treatment
Rather than stimulating immune cells to more effectively battle cancerous tumors, treatment with the protein interleukin-12 (IL-12) has the opposite effect, driving these intracellular fighters to exhaustion, a Mayo Clinic ...
Immunology
May 09, 2012 |
not rated yet |
0
Standard aplastic anemia therapy improves patient outcomes better than newer version
A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival significantly more than did Thymoglobulin, ...
Medical research
Aug 04, 2011 |
not rated yet |
0